Raymond James & Associates’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-884
Closed -$217K 3942
2022
Q3
$217K Sell
884
-2,067
-70% -$507K ﹤0.01% 3376
2022
Q2
$730K Buy
2,951
+1,328
+82% +$329K ﹤0.01% 2651
2022
Q1
$538K Sell
1,623
-997
-38% -$330K ﹤0.01% 3015
2021
Q4
$941K Sell
2,620
-844
-24% -$303K ﹤0.01% 2648
2021
Q3
$1.13M Sell
3,464
-122
-3% -$39.7K ﹤0.01% 2492
2021
Q2
$1.12M Sell
3,586
-4,704
-57% -$1.47M ﹤0.01% 2510
2021
Q1
$2.64M Buy
8,290
+1,314
+19% +$419K ﹤0.01% 1825
2020
Q4
$2.26M Sell
6,976
-272
-4% -$88.2K ﹤0.01% 1812
2020
Q3
$2.01M Buy
7,248
+1,534
+27% +$425K ﹤0.01% 1765
2020
Q2
$1.38M Buy
5,714
+773
+16% +$187K ﹤0.01% 1941
2020
Q1
$717K Sell
4,941
-4,274
-46% -$620K ﹤0.01% 2185
2019
Q4
$1.57M Sell
9,215
-26,179
-74% -$4.47M ﹤0.01% 1981
2019
Q3
$6.3M Sell
35,394
-2,317
-6% -$412K 0.01% 1100
2019
Q2
$9.82M Sell
37,711
-2,395
-6% -$624K 0.01% 866
2019
Q1
$11.5M Buy
40,106
+8,368
+26% +$2.39M 0.02% 746
2018
Q4
$10.3M Sell
31,738
-10,242
-24% -$3.33M 0.02% 740
2018
Q3
$18.9M Buy
41,980
+16,606
+65% +$7.47M 0.03% 554
2018
Q2
$10.4M Sell
25,374
-4,146
-14% -$1.7M 0.02% 798
2018
Q1
$8.59M Buy
29,520
+9,913
+51% +$2.88M 0.02% 860
2017
Q4
$3.68M Buy
19,607
+1,180
+6% +$221K 0.01% 1299
2017
Q3
$3.11M Buy
18,427
+5,656
+44% +$954K 0.01% 1339
2017
Q2
$1.83M Buy
12,771
+4,001
+46% +$573K ﹤0.01% 1623
2017
Q1
$1.1M Buy
8,770
+293
+3% +$36.7K ﹤0.01% 1918
2016
Q4
$955K Sell
8,477
-8,186
-49% -$922K ﹤0.01% 1945
2016
Q3
$2.14M Buy
16,663
+5,795
+53% +$745K 0.01% 1409
2016
Q2
$1.19M Sell
10,868
-182
-2% -$19.9K ﹤0.01% 1640
2016
Q1
$1.05M Buy
+11,050
New +$1.05M ﹤0.01% 1648
2015
Q1
Sell
-13,025
Closed -$496K 2409
2014
Q4
$496K Sell
13,025
-1,675
-11% -$63.8K ﹤0.01% 1943
2014
Q3
$365K Hold
14,700
﹤0.01% 1956
2014
Q2
$370K Buy
+14,700
New +$370K ﹤0.01% 1967
2013
Q3
Sell
-11,738
Closed -$253K 1991
2013
Q2
$253K Buy
+11,738
New +$253K ﹤0.01% 1761